These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27148914)

  • 21. Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature review.
    Bica BE; Moro AL; Hax V; Nicol NA; Campos GS; Rivera LM; da Costa AF; Xavier RM; Monticielo OA
    Lupus; 2015 Oct; 24(12):1327-31. PubMed ID: 25972366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catatonia and ECT across the lifespan.
    Karl S; Sartorius A; Aksay SS
    Schizophr Res; 2024 Jan; 263():246-251. PubMed ID: 37087393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vagal intimations for catatonia and electroconvulsive therapy.
    Dhossche DM
    J ECT; 2014 Jun; 30(2):111-5. PubMed ID: 24800686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ECT in the neuroleptic malignant syndrome: case report.
    Jessee SS; Anderson GF
    J Clin Psychiatry; 1983 May; 44(5):186-8. PubMed ID: 6133848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catatonia and autism: a historical review, with implications for electroconvulsive therapy.
    Dhossche DM; Reti IM; Wachtel LE
    J ECT; 2009 Mar; 25(1):19-22. PubMed ID: 19190507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Electroconvulsive Therapy in Autism.
    Park SE; Grados M; Wachtel L; Kaji S
    Child Adolesc Psychiatr Clin N Am; 2020 Jul; 29(3):455-465. PubMed ID: 32471595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response.
    Breit S; Meyer A; Schmitt W; Bracht T; Walther S
    Pharmacopsychiatry; 2024 Jan; 57(1):13-20. PubMed ID: 37995719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration.
    Makhinson M; Furst BA; Shuff MK; Kwon GE
    J ECT; 2012 Sep; 28(3):e35-6. PubMed ID: 22914637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory and Service System Challenges in Accessing Electroconvulsive Therapy for Catatonia in the Presence of Autism Spectrum Disorder.
    Couse M; Makhinson M; Kelly P
    J Am Acad Child Adolesc Psychiatry; 2024 Mar; 63(3):293-295. PubMed ID: 37778726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroconvulsive Treatment Utilization for Inpatient Management of Catatonia in Adolescents With Schizophrenia Spectrum Disorders.
    Patel RS; Hobart K; Wadhawan A; Chalia A; Youssef NA
    J ECT; 2022 Dec; 38(4):244-248. PubMed ID: 35623014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful use of right unilateral ECT for catatonia: a case series.
    Cristancho P; Jewkes D; Mon T; Conway C
    J ECT; 2014 Mar; 30(1):69-72. PubMed ID: 23859978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electroconvulsive therapy in combination with psychotropic and non-psychotropic pharmacological treatments: Review of the literature and practical recommendations].
    Quiles C; Dewitte A; Thomas P; Nunes F; Verdoux H; Amad A
    Encephale; 2020 Aug; 46(4):283-292. PubMed ID: 32151451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: A systematic review of cases.
    Warren N; Grote V; O'Gorman C; Siskind D
    Brain Stimul; 2019; 12(2):329-334. PubMed ID: 30528383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diminished ECT response in catatonia due to chronic neurologic condition.
    Swartz CM; Acosta D; Bashir A
    J ECT; 2003 Jun; 19(2):110-4. PubMed ID: 12792461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Legal restrictions on the use of ECT in California: clinical impact on the incompetent patient.
    Roy-Byrne P; Gerner RH
    J Clin Psychiatry; 1981 Aug; 42(8):300-3. PubMed ID: 7251565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia: a case report.
    Fernández-Corcuera P; Madre-Rull M; Amann BL
    Int Clin Psychopharmacol; 2015 Mar; 30(2):115-7. PubMed ID: 25438028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-injury in autism as an alternate sign of catatonia: implications for electroconvulsive therapy.
    Wachtel LE; Dhossche DM
    Med Hypotheses; 2010 Jul; 75(1):111-4. PubMed ID: 20202760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ECT and the youth: catatonia in context.
    Zaw FK
    Int Rev Neurobiol; 2006; 72():207-31. PubMed ID: 16697300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refusal of ECT by a patient with recurrent depression, psychosis, and catatonia.
    Boronow J; Stoline A; Sharfstein SS
    Am J Psychiatry; 1997 Sep; 154(9):1285-91. PubMed ID: 9286190
    [No Abstract]   [Full Text] [Related]  

  • 40. Electroconvulsive Treatment for Catatonia in Autism Spectrum Disorders.
    Withane N; Dhossche DM
    Child Adolesc Psychiatr Clin N Am; 2019 Jan; 28(1):101-110. PubMed ID: 30389070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.